XML 67 R52.htm IDEA: XBRL DOCUMENT v3.20.4
Liability Related to the Revenue Interest Purchase Agreement - Summary of Interest Liability (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Liability From Sale Of Future Revenues [Roll Forward]    
Oberland funding for regulatory approval of NEXLETOL $ 25,000  
Revenue Interest Purchase Agreement (RIPA)    
Liability From Sale Of Future Revenues [Roll Forward]    
Revenue interest liability at December 31, 2019 132,544  
Interest expense recognized 19,560 $ 8,100
Revenue interest payments (500)  
Revenue interest liability at December 31, 2020 $ 176,604 $ 132,544